117
Participants
Start Date
March 18, 2016
Primary Completion Date
January 17, 2018
Study Completion Date
October 21, 2021
Elotuzumab
Pomalidomide
Dexamethasone
Local Institution, South Brisbane
Azienda Ospedaliera Citta' Della Salute E Della Scienza Di Torino, Torino
Laiko University Hospital, Athens
Alexandra General Hospital Of Athens, Athens
Rochester General Hospital, Rochester
Va Pittsburgh Healthcare System, Pittsburgh
Local Institution - 0056, Kiel
Local Institution - 0024, Madrid
Carolinas Healthcare System, Charlotte
St Francis Hospital, Greenville
Winship Cancer Institute, Atlanta
Local Institution, Pamplona
Local Institution - 0020, Pessac
Tennessee Cancer Specialists, Knoxville
A. O. U. Di Bologna, Policlinico S. Orsola Malpighi, Bologna
Local Institution - 0022, Nantes
Local Institution, Valencia
Investigative Clinical Research Of Indiana, Llc, Indianapolis
Azienda Ospedaliera Universitaria Careggi, Florence
Klinikum Der Johannes Gutenberg Universitaet Mainz, Mainz
St. Barbara-Klinik, Hamm
Azienda Ospedaliero Universitaria Ospedali Riuniti Di Ancona, Ancona
Rush University Medical Center, Chicago
Local Institution - 0041, Heidelberg
Universitaetsklinikum Tuebingen, Tübingen
Local Institution - 0021, Paris
Universitaetsklinikum Freiburg, Freiburg im Breisgau
Northern Utah Associates, Ogden
Local Institution - 0019, Poitiers
Local Institution, Saint-Pierre
University Of Washington, Seattle
Local Institution - 0027, Shibuya-ku
Local Institution - 0028, Tachikawa-shi
Local Institution - 0067, Kasama-shi
Local Institution - 0030, Nagoya
Local Institution - 0031, Kyoto
Beth Israel Comprehensive Cancer Center, Boston
Dana Farber Cancer Institute., Boston
Local Institution, London
CISSS de l'Outaouais, Gatineau
Local Institution - 0048, Montreal
Universitaetsklinikum Carl Gustav Carus, Dresden
Local Institution, Roma
Universita' La Sapienza, Roma
Local Institution - 0069, Morioka
Local Institution - 0029, Niigata
Local Institution - 0032, Okayama
Local Institution, Amsterdam
Local Institution, Groningen
Local Institution, Maastrict
Local Institution, Utrecht
Oddzial Kliniczny Hematologii i Profilaktyki Chorob Nowotworowych, Chorzów
Local Institution, Lublin
Oddzial Hematologii i Transplantacji Szpiku, Poznan
Local Institution, Barcelona
Lead Sponsor
Celgene
INDUSTRY
AbbVie
INDUSTRY
Bristol-Myers Squibb
INDUSTRY